MIR1343: A Drug Target / Disease Biomarker (G100616437)
MIR1343: A Drug Target / Disease Biomarker
MIR1343 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the miRNA-protein complex, which plays a critical role in regulating gene expression. Several studies have identified MIR1343 as a potential drug target or biomarker, due to its unique structure and the potential it holds for therapeutic applications.
The MIR1343 protein is composed of a cytoplasmic domain and a transmembrane domain. The cytoplasmic domain contains a conserved N-terminal region that is involved in protein-protein interactions and may serve as a structural anchor. The transmembrane domain is made up of a variable number of transmembrane伪helices, which are involved in the protein's stability and may also be involved in its interactions with other molecules.
One of the key features of MIR1343 is its ability to interact with microRNA (miRNA) molecules. MiRNA is a small non-coding RNA molecule that plays a critical role in post-transcriptional gene regulation. MIR1343 has been shown to interact with several different miRNA molecules, including miR-18a, miR-202, and miR-214.
The interaction between MIR1343 and miR-18a is of particular interest, as this interaction has been shown to play a role in the regulation of neural development and plasticity. MIR1343 has been shown to physically interact with miR-18a, leading to the formation of a complex that is then targeted to the endoplasmic reticulum (ER) for degradation. This interaction between MIR1343 and miR-18a has been shown to play a role in the regulation of several neural development and plasticity-related genes, including genes involved in synaptic plasticity, differentiation, and cell survival.
Another potential drug target or biomarker for MIR1343 is its role in the regulation of cellular stress responses. MIR1343 has been shown to interact with the stress-responsive protein p180GAP, which is involved in the regulation of cellular stress responses. This interaction between MIR1343 and p180GAP has been shown to play a role in the regulation of cellular stress responses, including the regulation of inflammation and cellular apoptosis.
In addition to its potential role in drug targeting and biomarker development, MIR1343 is also of interest as a potential therapeutic target for several diseases. For example, MIR1343 has been shown to be involved in the regulation of cellular migration, which is a critical process for the development of cancer. In addition, MIR1343 has been shown to be involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed. This suggests that MIR1343 may be a useful target for diseases that involve the regulation of angiogenesis, such as cancer.
In conclusion, MIR1343 is a protein that has unique structural features and has been shown to interact with several different miRNA molecules. Its ability to interact with miRNA molecules and its potential role in the regulation of cellular stress responses and angiogenesis make it an attractive target for drug development and biomarker research. Further studies are needed to fully understand the potential of MIR1343 as a drug target or biomarker.
Protein Name: MicroRNA 1343
The "MIR1343 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1343 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR135A1 | MIR135A2 | MIR135B | MIR136 | MIR137 | MIR137HG | MIR138-1 | MIR138-2 | MIR139 | MIR140 | MIR141 | MIR142 | MIR143 | MIR144 | MIR145 | MIR1468 | MIR1469 | MIR146A | MIR146B | MIR1470 | MIR1471 | MIR147A | MIR147B | MIR148A | MIR148B | MIR149 | MIR150 | MIR151A | MIR151B | MIR152 | MIR153-1 | MIR153-2 | MIR1537 | MIR1538 | MIR1539 | MIR154 | MIR155 | MIR155HG | MIR1587 | MIR15A | MIR15B | MIR16-1 | MIR16-2 | MIR17 | MIR17HG | MIR181A1 | MIR181A1HG | MIR181A2 | MIR181A2HG | MIR181B1 | MIR181B2 | MIR181C | MIR181D | MIR182 | MIR1825 | MIR1827 | MIR183 | MIR184 | MIR185 | MIR186 | MIR187 | MIR188 | MIR18A | MIR18B | MIR1908 | MIR1909 | MIR190A | MIR190B | MIR191 | MIR1910 | MIR1911 | MIR1912 | MIR1913 | MIR1914 | MIR1915 | MIR1915HG | MIR192 | MIR193A | MIR193B | MIR193BHG | MIR194-1 | MIR194-2 | MIR194-2HG | MIR195 | MIR196A1 | MIR196A2 | MIR196B | MIR197 | MIR1972-1 | MIR1972-2 | MIR1973 | MIR1976 | MIR198 | MIR199A1 | MIR199A2 | MIR199B | MIR19A | MIR19B1 | MIR19B2 | MIR200A
